Shino-Test

Shino-Test Corporation is a Japanese medical diagnostics company founded in 1951, specializing in the development, manufacture, and sale of in vitro diagnostic (IVD) reagents and laboratory instruments. The company is a pioneer in clinical chemistry, notably being the first in the world to succeed in the enzymatic measurement of glycated hemoglobin (HbA1c). Its product portfolio covers a wide range of clinical testing areas, including diabetes management, lipid metabolism, inflammatory markers, and liver function. Shino-Test provides high-quality diagnostic solutions to hospitals and clinical laboratories globally, often through partnerships with major global diagnostic players.